Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Price (Quote)

$0.255
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.255 $0.255 Friday, 27th May 2022 CNAT stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.238 $0.275
52 weeks $0.203 $1.23

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jul 21, 2016 $2.18 $2.21 $2.16 $2.19 29 700
Jul 20, 2016 $2.12 $2.21 $2.10 $2.16 62 500
Jul 19, 2016 $2.27 $2.30 $2.14 $2.14 60 300
Jul 18, 2016 $2.25 $2.29 $2.23 $2.29 130 500
Jul 15, 2016 $2.16 $2.29 $2.16 $2.25 109 000
Jul 14, 2016 $2.15 $2.18 $2.11 $2.16 29 800
Jul 13, 2016 $2.20 $2.23 $2.13 $2.15 50 200
Jul 12, 2016 $2.21 $2.24 $2.19 $2.20 63 600
Jul 11, 2016 $2.23 $2.24 $2.16 $2.21 39 600
Jul 08, 2016 $2.12 $2.20 $2.11 $2.19 72 900
Jul 07, 2016 $2.20 $2.26 $2.07 $2.19 59 400
Jul 06, 2016 $2.22 $2.23 $2.05 $2.18 63 100
Jul 05, 2016 $2.19 $2.25 $2.15 $2.20 146 500
Jul 01, 2016 $2.13 $2.44 $2.07 $2.18 892 400
Jun 30, 2016 $2.15 $2.16 $2.04 $2.06 64 900
Jun 29, 2016 $2.03 $2.24 $2.00 $2.16 101 700
Jun 28, 2016 $2.04 $2.06 $2.02 $2.03 30 100
Jun 27, 2016 $2.02 $2.06 $1.97 $2.00 156 200
Jun 24, 2016 $2.04 $2.09 $1.94 $2.04 117 900
Jun 23, 2016 $2.05 $2.19 $2.05 $2.13 70 100
Jun 22, 2016 $2.07 $2.10 $2.02 $2.04 38 300
Jun 21, 2016 $2.25 $2.35 $1.95 $2.06 233 100
Jun 20, 2016 $1.95 $2.24 $1.94 $2.23 336 300
Jun 17, 2016 $1.94 $1.98 $1.89 $1.92 78 600
Jun 16, 2016 $1.92 $1.97 $1.91 $1.93 49 956
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT